NLRP12.com's blog with news, updates and comments on all things rare and autoinflammatory

  • Home
  • To NLRP12.com web site

Pharma

A Nuanced Message: Marketing to the Rare Diseases Community

May 10, 2017 John 0

Check traditional marketing strategies at the door, because when it comes to rare diseases they simply don’t apply. Experts say established methods of directing campaigns […]

PatientsLikeMe

PatientsLikeMe and Shire to co-develop rare disease patient network

May 9, 2017 John 0

PatientsLikeMe and Shire are to work together to better understand rare disease patient health and disease progression. PatientsLikeMe is now a well-established online community of […]

Pharma Prices

Big Pharma Losing Leverage as Payers Raise Pressure on Price

May 7, 2017 John 0

Consolidation among insurers, pharmacy benefit managers key Drug companies are citing growth by volume instead of price Byline: Jared S. Hopkins and Doni Bloomfield, Bloomberg […]

Prices of Drugs Rare Disease

Ultra-rare disease drugs: has access in England just got harder?

May 6, 2017 John 0

Story from Andrew McConaghie on PharmaPhorum New rules on market access introduced by NICE from 1 April will affect most new medicines – but gaining […]

Navigation

  • Home
  • To NLRP12.com web site
  • FCAS2
  • NLRP12
  • Ultra Rare
  • Autoinflammatory
  • Drugs
    • Orphan Drugs
  • Pharma
  • Genetics
  • Autoimmune
  • Software
  • Rare Disease
  • Ultra Rare
  • UK
    • Scotland
      • NHS Scotland
    • Northern Ireland
    • Wales
    • England
  • USA
  • Campaigning
  • Uncategorized

What advice would you give to others?

  • Humane Resources: Funding Restrictions in Rare Rheumatic Diseases
  • Rare Disease Clinical Development: The Crucial Need for Patient and Parent Involvement
  • Living with a rare disease: a husband and father’s perspective
  • Global Genes® to Convene RARE Partnering and Investor Forum to Accelerate Drug Development for Rare Diseases
  • Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays.
  • We must act as England falls behind on access to rare disease medicines
  • App-based tool for clinicians using facial recognition, AI and genetic big data to improve rare disease diagnosis and treatment
  • Three new medicines cleared for use by NHS Scotland
  • NORD Launches Free CME Program to Educate Medical Professionals about Rare Diseases
  • A Nuanced Message: Marketing to the Rare Diseases Community
Advocacy Australian Autoimmune Autoinflammatory Campaigning Child Drug Costs England Genetics Hereditory Immune System India LHON Lifestyle Marketing NHS Scotland Pharma Rare Disease Rare Disease Marketing Rare Disease Registry SLE SMC UK ultra-rare USA
No comments found

Archives

| Privacy Policy | Terms & Conditions |
| Cookie Policy | Disclaimer |
Nothing on this blog is medical advice. This blog is for INFORMATION only.
If you need medical advice, please call a medical professional.

Copyright © 2023 | WordPress Theme by MH Themes